Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 4 sources · 5 days · First seen 15 days ago · Last updated 10 days ago

Diabetes health risks and medication complications

Overview

Medical research has highlighted various health complications and risks associated with diabetes and its treatments. Studies utilizing Medicare data indicated that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may be linked to increased risks of kidney and endometrial cancers when compared to other medications. Additionally, a review of clinical trials found that sodium-glucose cotransporter 2 inhibitors (SGLT2is) are associated with a higher incidence of genital infections.

Further research in England has identified that infection is a leading underlying cause of death for individuals with type 2 diabetes, following cardiovascular disease and cancer. The risk of hospitalization due to infection is notably higher for those with type 1 diabetes. To mitigate these risks, studies suggest that adherence to an ‘ideal’ lifestyle—including regular physical activity, adequate sleep, and not smoking—can significantly reduce the incidence of infections, including pneumonia and sepsis.

Entities

American Diabetes Association · City St George’s, University of London · UK Biobank · Medicare

Timeline

10 days ago

[HEALTH] 2 sources
Diabetes increases infection and mortality risks
Studies show diabetes significantly increases infection and mortality risks, but adhering to a healthy lifestyle may reduce infection incidence in type 2 diabetes patients by approximately 44 percent.
15 days ago

[HEALTH] 2 sources
Diabetes medications linked to increased cancer and infection risks
Medical studies link GLP-1 receptor agonists to increased kidney and endometrial cancer risks, while SGLT2 inhibitors are associated with a higher risk of genital mycotic infections in diabetes patients.

Sources

2minutemedicine.com · digitalcommons.library.tmc.edu · jdc.jefferson.edu · tribuneonlineng.com